Chromosomal localization of genes encoding CAN/Nup214-interacting proteins - Human CRM1 localizes to 2p16, whereas Nup88 localizes to 17p13 and is physically linked to SF2p32

Genomics

Volumn 42, Issue 3, 1997, Pages 538-540

  Fornerod, Maarten ^a   Van Baal, Sjozef ^a   Valentine, Virginia ^a   Shapiro, David N ^a   Grosveld, Gerard ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTIG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMOSOMAL LOCALIZATION; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 6; GENETIC LINKAGE; HUMAN; IN SITU HYBRIDIZATION; LYMPHOCYTE; PRIORITY JOURNAL; PROTO ONCOGENE; RNA SPLICING;

EID: 0031570684     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.4767     Document Type: Article

References (15)

1. 1. Balciuniene, J., Johansson, K., Sandgren, O., Wachtmeister, L., Holmgren, G., and Forsman, K. (1995). A gene for autosomal dominant progressive cone dystrophy (CORD5) maps to chromosome 17p12-p13. Genomics 30: 281-286.
2. 2. Camuzat, A., Rozet, J. M., Dollfus, H., Gerber, S., Perrault, I., Weissenbach, J., Munnich, A., and Kaplan, J. (1996). Evidence of genetic heterogeneity of Leber's congenital amaurosis (LCA) and mapping of LCA1 to chromosome 17p13. Hum. Genet. 97: 798-801.
3. 3. Fornerod, M., Boer, J., van Baal, S., Morreau, H., and Grosveld, G. (1996). Interaction of cellular proteins with the leukemia specific fusion proteins DEK-CAN and SET-CAN and their normal counterpart, the nucleoporin CAN. Oncogene. 13: 1801-1808.
4. 4. Fornerod, M., van Deursen, J., van Baal, S., Reynolds, A., Davis, D., Murti, K. G., and Grosveld, G. (1997). The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/ Nup214 and a novel nuclear pore component Nup88. EMBO J. 16: 807-816.
5. 5. Goliath, R., Shugard, Y., Janssens, P., Weissenbach, J., Beighton, P., Ramasar, R., and Greenberg, J. (1995). Fine localization of the locus for autosomal dominant retinitis pigmentosa on chromosome 17p. Am. J. Hum. Genet. 57: 962-965.
6. 6. Honore, B., Madsen, P., Rasmussen, H. H., Vandekerckhove, J., Celis, J. E., and Leffers, H. (1993). Cloning and expression of a cDNA covering the complete coding region of the P32 subunit of human pre-mRNA splicing factor SF2. Gene 134: 283-287.
7. 7. Hudson, T., Stein, L., Gerety, S., Ma, J., Castle, A., Silva, J., Slonim, D., Baptista, R., Kruglyak, L., et al. (1995). An STS-based map of the human genome. Science 270: 1945-1954.
8. 8. Jean, G., Fuchshuber, A., Town, M. M., Gribouval, O., Schneider, J. A., Broyer, M., van't Hoff, W., Niaudet, P., and Antignac, C. (1996). High-resolution mapping of the gene for cysteinosis, using combined biochemical and linkage analysis. Am. J. Hum. Genet. 58: 535-543.
9. 9. Kojis, T. L., Heinzmann, C., Flodman, P., Ngo, J. T., Sparkes, R. S., Spence, M. A., Bateman, J. B., and Heckenlively, J. R. (1996). Map refinement of locus RP13 to human chromosome 17p13.3 in a second family with autosomal dominant retinitis pigmentosa. Am. J. Hum. Genet. 58: 347-355.
10. 10. Lichter, P., Tang, C. J., Call, K., Hermanson, G., Evans, G. A., Housman, D., and Ward, D. C. (1990). High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247: 64-69.
11. 11. Mitelman, F. (1994). "Catalog of Chromosome Aberrations in Cancer," Vol. 4, Wiley-Liss, New York.
12. 2 arrest and impaired nucleocytoplasmic transport in mouse embryos lacking the proto-oncogene CAN/Nup214. EMBO J. 15: 5574-5583.
13. 13. von Lindern, M., Fornerod, M., van Baal, S., Jaeglé, M., de Wit, T., Buijs, A., and Grosveld, G. (1992). The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol. Cell. Biol. 12: 1687-1697.
14. 14. von Lindern, M., Poustka, A., Lerach, H., and Grosveld, G. (1990). The (6; 9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34. Mol. Cell. Biol. 10: 4016-4026.
15. 15. von Lindern, M., van Baal, S., Wiegant, J., Raap, A., Hagemeijer, A., and Grosveld, G. (1992). Can, a putative oncogene associated with myeloid leukemogenesis, can be activated by fusion of its 3′ half to different genes: Characterization of the set gene. Mol. Cell. Biol. 12: 3346-3355.